HealthCare Africa News December 5, 2022

HealthCare Africa News December 5, 2022

AFRICAN NEWS HEADLINES

Dengue fever cases rise in Sudan, the worst outbreak in years

No alt text provided for this image

SUDAN?– The Sundanese health ministry has reported that the total number of suspected dengue fever cases in Sudan has exceeded 4,000 as the country struggles to battle one of its worst dengue fever outbreaks in years. . .?Read More

Africa is set to receive its first batch of Mpox vaccine

No alt text provided for this image

AFRICA?– The government of the Republic of Korea, through Korea Disease Control and Prevention Agency (KDCA), is set to donate the first batch of the Mpox vaccine to Africa through the Africa CDC?. . .?Read More

Egypt launches new insulin production line for exportation to African countries

No alt text provided for this image

EGYPT?– Egypt announced the launch of a new high-capacity insulin production line by Egypt’s Medical Union Pharmaceutical Company (MUP), to export to African countries as soon as it attains self-sufficiency. . .Read More

Namibia revises its medicine policy to be more responsive to emerging health needs

No alt text provided for this image

NAMIBIA?– The Ministry of Health and Social Services has launched a revised National Medicines Policy (NMP), after 24 years, to guide and develop pharmaceutical services in the country to meet the requirements of locals in the prevention, diagnosis, and treatment of diseases?. . .Read More

Nagasaki University to train Kenyan scientists on vaccine development

No alt text provided for this image

KENYA?– Japan’s Nagasaki University will from 2023 work with KEMRI Graduate School (KGS) in high-level training of KEMRI and Kenyan scientists in vaccine development, from basic science and product development to clinical trials?. . .?Read More

GLOBAL?NEWS HEADLINES

Biocon closes US$3bn deal for Viatris Biosimilars

No alt text provided for this image

INDIA?— Biocon has reached a significant milestone after its Biocon Biologics subsidiary closed a $3 billion deal to acquire Viatris' biosimilars business, in what management described as a "historic inflection point" for the Indian player. . .?Read More

Experimental drug appears to slow progression of Alzheimer’s disease

No alt text provided for this image

USA?— Experimental drug lecanemab appears to slow the progression of Alzheimer's disease, according to clinical trial results of the drug makers published in the New England Journal of Medicine?. . .?Read More

EU’s new global health strategy underscores stronger international rules and cooperation?

No alt text provided for this image

BELGIUM?— The European Union Commission?has unveiled a new global health strategy that is anchored on three pillars propelled by stronger international health rules and health cooperation mechanisms?.?. .?Read More

WHO's Director General announces five new appointments

No alt text provided for this image

SWITZERLAND?— Dr. Tedros Adhanom Ghebreyesus, Director General of WHO, has announced the "interim" appointment of five new senior leaders to replace outgoing members of his senior team?.?. .Read More

Pharma giants probe takeover of Horizon Therapeutics

No alt text provided for this image

IRELAND?— Horizon Therapeutics, a Dublin-based manufacturer of drugs for rare and inflammatory diseases, has piqued the interest of several large pharmaceutical companies and has confirmed that it is in "highly preliminary" talks with Amgen, Johnson & Johnson, and Sanofi about a possible takeover?.?. .Read More

要查看或添加评论,请登录

HealthCare Middle East & Africa Magazine的更多文章

社区洞察

其他会员也浏览了